Emerging Molecular Biomarkers for GU Cancer

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

OUR INSANE HOUSE PARTY GONE WRONG! -You Should Know Podcast- 1h 21m · 21 Sep 2026 · You Should Know Podcast

Where is Austin Tice? 1. 'We believe he’s alive' 34 min · 21 Sep 2026 · The Documentary Podcast

Arsenal battered in Brighton as Manchester City go clear: Football Weekly 54 min · 21 Sep 2026 · Football Weekly

NPR News: 09-21-2026 8AM EDT 4 min · 21 Sep 2026 · NPR News Now

The Data Gold Rush_ Who Really Owns Your Digital Footprint 2 min · 21 Sep 2026 · Conspiracy Theories Exploring The Unseen

8AM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded28 Sep 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648215

Show notes

Omar Mian, MD, PhD, radiation oncologist, and physician scientist, joins the Cancer Advances Podcast to talk about emerging molecular biomarkers for genitourinary cancers. During the episode, Dr. Mian explains the multidisciplinary approach required for effective biomarker utilization, the success of prognostic and predictive biomarkers, and his ongoing research on germline polymorphisms and the use of PET scans with PSMA tracers.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in